CardioFocus Believes US AFib Market Is Ready For Its HeartLight Balloon Catheter
This article was originally published in Clinica
CardioFocus plans to launch its HeartLight laser ablation catheter, only the second balloon-type ablation catheter approved by the US FDA, in select US accounts by July.
You may also be interested in...
Starts & Stops: CardioFocus Studies HeartLight X3 In Persistent AF; IntraLink Spine Launches Trial Of Low-Back Device In Australia
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from March 4 through March 17, including trial announcements from CardioFocus, Innovative Cardiovascular Solutions, IntraLink-Spine, Geneveve, Acutus, and Stereotaxis.
The American Medical Association has written a set of principles for augmented intelligence (AI) development and deployment in health care. The organization hopes these principles can shape “a consistent governance structure for advancements in health care technology.”
Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.